A Publisher Correction to this article was published on 17 March 2023This article has been updatedAbstract ALLO-715 is a first-in-class, allogeneic, anti-BCMA CAR T cell therapy engineered to abrogate graft-versus-host disease and minimize CAR T rejection. We evaluated escalating doses of ...
CMA Dec 2024 results out; Know what's next for CMA Inter, Final students? Feb 14, 2025 CMA Inter Exam Dates June 2025 (OUT) - Check Complete Schedule Feb 14, 2025 CMA June 2025 Exam Dates Soon: Check expected timetable here Feb 11, 2025 CMA Inter Result Dec 2024 (Out), Direct Lin...
Updated results of talquetamab, a GPRC5D×CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma with prior exposure to T-cell redirecting therapies: results of the phase 1/2 MonumenTAL-1 study [abstract] Blood, 142 (suppl 1) (2023), p. 3377 View PDFView articleCross...
Sections Figures References Abstract Introduction Materials and methods Results Discussion Data availability Abbreviations References Acknowledgements Funding Author information Ethics declarations Additional information Supplementary Information Rights and permissions About this articleDiscover...
CMAM30 and ERA results show that the amplitudes of non-migrating tides, DS0 and DW2, are negligible in the mid and high-latitude stratosphere, and the results from satellite datasets are significantly affected by aliasing in this region, in spite of using a smaller window size for analysis (...